OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Efficacy and safety of sacubitril/valsartan compared with olmesartan in Asian patients with essential hypertension: A randomized, double‐blind, 8‐week study
Yong Huo, Weimin Li, Randy L. Webb, et al.
Journal of Clinical Hypertension (2018) Vol. 21, Iss. 1, pp. 67-76
Open Access | Times Cited: 54
Yong Huo, Weimin Li, Randy L. Webb, et al.
Journal of Clinical Hypertension (2018) Vol. 21, Iss. 1, pp. 67-76
Open Access | Times Cited: 54
Showing 26-50 of 54 citing articles:
The protective effects of Olmesartan against interleukin-29 (IL-29)-induced type 2 collagen degradation in human chondrocytes
Yunlong Liu, Junyi Liu, Yan Ma, et al.
Bioengineered (2022) Vol. 13, Iss. 1, pp. 1802-1813
Open Access | Times Cited: 6
Yunlong Liu, Junyi Liu, Yan Ma, et al.
Bioengineered (2022) Vol. 13, Iss. 1, pp. 1802-1813
Open Access | Times Cited: 6
Sacubitril-Valsartan Increases Ultrafiltration in Patients Undergoing Peritoneal Dialysis: A Short-Term Retrospective Self-Controlled Study
Fen Zhang, Tingting Zhang, Sisi Yang, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 6
Fen Zhang, Tingting Zhang, Sisi Yang, et al.
Frontiers in Medicine (2022) Vol. 9
Open Access | Times Cited: 6
Development of Transdermal Oleogel Containing Olmesartan Medoxomil: Statistical Optimization and Pharmacological Evaluation
Rania Moataz El-Dahmy, Ibrahim Elsayed, Jihan Hussein, et al.
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1083-1083
Open Access | Times Cited: 3
Rania Moataz El-Dahmy, Ibrahim Elsayed, Jihan Hussein, et al.
Pharmaceutics (2023) Vol. 15, Iss. 4, pp. 1083-1083
Open Access | Times Cited: 3
Sacubitril/Valsartan in Heart Failure with Hypertension Patients: Real-World Experiences on Different Ages, Drug Doses, and Renal Functions
Ying‐Yun Guan, Xiaoye Li, Hui Li, et al.
High Blood Pressure & Cardiovascular Prevention (2023) Vol. 30, Iss. 6, pp. 561-572
Closed Access | Times Cited: 3
Ying‐Yun Guan, Xiaoye Li, Hui Li, et al.
High Blood Pressure & Cardiovascular Prevention (2023) Vol. 30, Iss. 6, pp. 561-572
Closed Access | Times Cited: 3
Efficacy and Dosage Pattern of Sacubitril/Valsartan in Chinese Heart Failure with Reduced Ejection Fraction Patients
Iokfai Cheang, Shi Shi, Xinyi Lu, et al.
Journal of Cardiovascular Translational Research (2022) Vol. 15, Iss. 5, pp. 1192-1202
Open Access | Times Cited: 5
Iokfai Cheang, Shi Shi, Xinyi Lu, et al.
Journal of Cardiovascular Translational Research (2022) Vol. 15, Iss. 5, pp. 1192-1202
Open Access | Times Cited: 5
Efficacy and safety of sacubitril/valsartan in the treatment of middle-aged and elderly patients with hypertension: a systematic review and meta-analysis of randomized controlled trials
Hong-Xing Wu, Keke Liu, Bo‐Ning Li, et al.
Annals of Palliative Medicine (2022) Vol. 11, Iss. 5, pp. 1811-1825
Open Access | Times Cited: 5
Hong-Xing Wu, Keke Liu, Bo‐Ning Li, et al.
Annals of Palliative Medicine (2022) Vol. 11, Iss. 5, pp. 1811-1825
Open Access | Times Cited: 5
Cost Effectiveness of the First‐in‐Class ARNI (Sacubitril/Valsartan) for the Treatment of Essential Hypertension in a Chinese Setting
Xinyue Dong, Xiaoning He, Jing Wu
PharmacoEconomics (2022) Vol. 40, Iss. 12, pp. 1187-1205
Closed Access | Times Cited: 4
Xinyue Dong, Xiaoning He, Jing Wu
PharmacoEconomics (2022) Vol. 40, Iss. 12, pp. 1187-1205
Closed Access | Times Cited: 4
Network meta-analysis of sacubitril/valsartan for the treatment of essential hypertension
Yaling Zhang, Xiaoyu Zhao, Hao Huang, et al.
Clinical Research in Cardiology (2022) Vol. 112, Iss. 7, pp. 855-867
Open Access | Times Cited: 4
Yaling Zhang, Xiaoyu Zhao, Hao Huang, et al.
Clinical Research in Cardiology (2022) Vol. 112, Iss. 7, pp. 855-867
Open Access | Times Cited: 4
The Effects of Sacubitril/Valsartan Compared to Olmesartan on the Blood Pressure and Glucolipid Metabolism in DM Patients with Primary Hypertension
Shuang Zhang, Yin Zheng, Zhi-Fan Li, et al.
Cardiovascular Drugs and Therapy (2023)
Closed Access | Times Cited: 2
Shuang Zhang, Yin Zheng, Zhi-Fan Li, et al.
Cardiovascular Drugs and Therapy (2023)
Closed Access | Times Cited: 2
A Meta-Analysis on the Effect and Safety of LCZ696 in the Treatment of Hypertension
Li Zheng, Binbin Xia, Xuqian Zhang, et al.
Cardiology Research and Practice (2021) Vol. 2021, pp. 1-10
Open Access | Times Cited: 4
Li Zheng, Binbin Xia, Xuqian Zhang, et al.
Cardiology Research and Practice (2021) Vol. 2021, pp. 1-10
Open Access | Times Cited: 4
Nuevas perspectivas en el manejo de la hipertensión
Eduardo Fasce H, Luis Hernán Zárate
Revista médica de Chile (2021) Vol. 149, Iss. 1, pp. 88-97
Open Access | Times Cited: 4
Eduardo Fasce H, Luis Hernán Zárate
Revista médica de Chile (2021) Vol. 149, Iss. 1, pp. 88-97
Open Access | Times Cited: 4
Angiotensin Receptor Neprilysin Inhibitors—2019 Update
Georgios Chalikias, Dimitrios Tziakas
Cardiovascular Drugs and Therapy (2020) Vol. 34, Iss. 5, pp. 707-722
Closed Access | Times Cited: 3
Georgios Chalikias, Dimitrios Tziakas
Cardiovascular Drugs and Therapy (2020) Vol. 34, Iss. 5, pp. 707-722
Closed Access | Times Cited: 3
Benefits of sacubitril/valsartan use in patients with chronic heart failure after cardiac valve surgery: a single-center retrospective study
Jian Zheng, Qingsong Wu, Qianzhen Li, et al.
Journal of Cardiothoracic Surgery (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 1
Jian Zheng, Qingsong Wu, Qianzhen Li, et al.
Journal of Cardiothoracic Surgery (2023) Vol. 18, Iss. 1
Open Access | Times Cited: 1
Efficacy and Safety Comparative of Sacubitril/Valsartan vs. Olmesartan in the Treatment of hypertension: A Meta-analysis of RCTs
Yongjin Han, Ying Zhou, Na Jing, et al.
American Journal of Hypertension (2023) Vol. 36, Iss. 12, pp. 643-650
Open Access | Times Cited: 1
Yongjin Han, Ying Zhou, Na Jing, et al.
American Journal of Hypertension (2023) Vol. 36, Iss. 12, pp. 643-650
Open Access | Times Cited: 1
Sacubitril-Valsartan (LCZ696) in the Treatment of Systemic Hypertension: An Updated Review of Neprilysin Inhibition Combined with Angiotensin II Receptor Blockade
Miriam Katz, William H. Frishman, Wilbert S. Aronow
Cardiology in Review (2024)
Closed Access
Miriam Katz, William H. Frishman, Wilbert S. Aronow
Cardiology in Review (2024)
Closed Access
Comparison of sacubitril/valsartan with olmesartan for hypertension: A meta-analysis of randomized controlled trials
Ying Sun, Hua Yang
Medicine (2024) Vol. 103, Iss. 14, pp. e37501-e37501
Open Access
Ying Sun, Hua Yang
Medicine (2024) Vol. 103, Iss. 14, pp. e37501-e37501
Open Access
Does Speckle Tracking Transthoracic Echocardiography Indicate Subtle Changes in Left Ventricular Function in Heart Failure Patients with Reduced Ejection Fraction Treated by Sacubitril-valsartan?
Amr Setouhi, Osama Mohamed, Hazem M. A. Farrag, et al.
Journal of Cardiovascular Echography (2024) Vol. 34, Iss. 1, pp. 19-24
Closed Access
Amr Setouhi, Osama Mohamed, Hazem M. A. Farrag, et al.
Journal of Cardiovascular Echography (2024) Vol. 34, Iss. 1, pp. 19-24
Closed Access
Clinical Benefit of Sacubitril/Valsartan for Hypertensive Patients in Daily Practice and Predictors of Its Antihypertensive Effect
Takeshi Horio, Yoshio Iwashima, Minoru Yoshiyama, et al.
Circulation Reports (2024) Vol. 6, Iss. 7, pp. 248-254
Open Access
Takeshi Horio, Yoshio Iwashima, Minoru Yoshiyama, et al.
Circulation Reports (2024) Vol. 6, Iss. 7, pp. 248-254
Open Access
Efficacy and Safety of Sacubitril/Valsartan in Adverse Cardiovascular Event Reduction and Hypertension Control Among Asians: A Systematic Review and Meta-analysis of Randomized Controlled Trials
Patrick Vera Cruz, Wisdom Ang, Jose Bernardo Calatrava
Philippine journal of cardiology. (2024) Vol. 52, Iss. 1, pp. 33-44
Closed Access
Patrick Vera Cruz, Wisdom Ang, Jose Bernardo Calatrava
Philippine journal of cardiology. (2024) Vol. 52, Iss. 1, pp. 33-44
Closed Access
Efficacy and Safety of LCZ696 for Short-term Management of Essential Hypertension Compared With ARBs: A Meta-analysis of Randomized Controlled Trials
Shuai Yang, Hongzhou Zhang, Pingping Yang, et al.
Journal of Cardiovascular Pharmacology (2021) Vol. 77, Iss. 5, pp. 650-659
Closed Access | Times Cited: 3
Shuai Yang, Hongzhou Zhang, Pingping Yang, et al.
Journal of Cardiovascular Pharmacology (2021) Vol. 77, Iss. 5, pp. 650-659
Closed Access | Times Cited: 3
Chronic brain ischemia: from risk factors to cerebrovascular complications
F. A. Yusupov, SHAROF ZHUMABAEVICH NURMATOV, GULBARA TOPCHUBAEVNA AMANBAEVA, et al.
Scientific and practical journal Healthcare of Kyrgyzstan (2021), Iss. 3, pp. 80-89
Closed Access | Times Cited: 1
F. A. Yusupov, SHAROF ZHUMABAEVICH NURMATOV, GULBARA TOPCHUBAEVNA AMANBAEVA, et al.
Scientific and practical journal Healthcare of Kyrgyzstan (2021), Iss. 3, pp. 80-89
Closed Access | Times Cited: 1
The Symphony of Survival: Sacubitril/Valsartan’s Heartfelt Impact on Mortality in Heart Failure: A Systemic Review
Eshwar Kumar Burra, Kamran Shahid, Yonas Tamene, et al.
Journal For International Medical Graduates (2023) Vol. 2, Iss. 2
Open Access
Eshwar Kumar Burra, Kamran Shahid, Yonas Tamene, et al.
Journal For International Medical Graduates (2023) Vol. 2, Iss. 2
Open Access
Dose-dependent Reduction of Blood Pressure by Angiotensin Receptor-neprilysin Inhibitor: A Network Meta-analysis
Ting‐Wei Kao, Yi-Chih Lee
Research in Cardiovascular Medicine (2023) Vol. 12, Iss. 1, pp. 19-25
Open Access
Ting‐Wei Kao, Yi-Chih Lee
Research in Cardiovascular Medicine (2023) Vol. 12, Iss. 1, pp. 19-25
Open Access
Antihypertensive Effects of Sacubitril/Valsartan Versus Olmesartan: An Updated Systemic Review and Meta-Analysis of Randomized Controlled Trials
Roomi Raja, Sandhya Kumari, Muhammad Umer Khan, et al.
Cureus (2023)
Open Access
Roomi Raja, Sandhya Kumari, Muhammad Umer Khan, et al.
Cureus (2023)
Open Access
A Nomogram model for the early warning of essential hypertension risks based on the principles of traditional Chinese medicine syndrome elements
Zhuo Zewei, Zhang Fei, Yang Chengwei, et al.
Digital Chinese Medicine (2023) Vol. 6, Iss. 3, pp. 245-256
Open Access
Zhuo Zewei, Zhang Fei, Yang Chengwei, et al.
Digital Chinese Medicine (2023) Vol. 6, Iss. 3, pp. 245-256
Open Access
